AduPARE1A and gemcitabine combined treatment trigger synergistic antitumor effects in pancreatic cancer through NF-κB mediated uPAR activation

BACKGROUND: Combined treatment of oncolytic adenoviruses with chemotherapeutic agents is foreseen as a therapeutic option for cancer. Here we have investigated the potential to use gemcitabine in combination with the oncolytic adenovirus AduPARE1A to treat pancreatic cancer and evaluate the underlyi...

Descripción completa

Detalles Bibliográficos
Autores principales: Maliandi, Maria Victoria, Mato-Berciano, Ana, Sobrevals, Luciano, Roué, Gaël, José, Anabel, Fillat, Cristina
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2015
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4521493/
https://www.ncbi.nlm.nih.gov/pubmed/26227809
http://dx.doi.org/10.1186/s12943-015-0413-2

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4521493/
https://www.ncbi.nlm.nih.gov/pubmed/26227809
http://dx.doi.org/10.1186/s12943-015-0413-2

Ejemplares similares